Andrew Technologies

Andrew Technologies is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology. The first product utilizing TLT was launched by Alcon in 2003 for cataract surgery. In 2012, the FDA approved the HydraSolve:registered: Lipoplasty System.